Table 5.

Cut-off score of Hsp90-beta serum level for differentiating lung cancer patients from normal and benign groups

Selection of cut-off score for serum value of Hsp90-beta in lung cancer patients and healthy examined peoples
Criterion	Sensitivity	95% CI	Specificity	95% CI
> 1.1058	100.00	95.5-100.0	73.81	63.1-82.8
> 1.1438	98.77	93.3-100.0	78.57	68.3-86.8
> 1.1552*	98.77	93.3-100.0	83.33	73.6-90.6
> 1.173	90.12	81.5-95.6	85.71	76.4-92.4
> 1.212	87.65	78.5-93.9	92.86	85.1-97.3
> 1.232	85.19	75.6-92.1	95.24	88.3-98.7
> 1.2806	75.31	64.5-84.2	100.00	95.7-100.0
Selection of cut-off score for serum value of Hsp90-beta in lung cancer patients and benign lung disease patients
Criterion	Sensitivity	95% CI	Specificity	95% CI
> 1.097	100.00	98.6-100.0	57.73	50.9-64.3
> 1.12	98.51	96.2-99.6	57.73	50.9-64.3
> 1.1331	98.51	96.2-99.6	67.27	60.6-73.4
> 1.1578*	95.90	92.8-97.9	72.27	65.9-78.1
> 1.232	84.33	79.4-88.5	74.55	68.3-80.2
> 1.2965	72.76	67.0-78.0	93.18	89.0-96.1
> 1.3212	63.81	57.7-69.6	95.45	91.8-97.8
> 1.3706	38.81	32.9-44.9	100.00	98.3-100.0

95% CI, 95% confidence;

^*threshold of serum annexin A1 for differentiating lung cancer patient from benign lung disease patient and normal people.